Alpha 2.0
Login Register
» Articles » PMID: 22513150

Tocilizumab for Treating Refractory Haemolytic Anaemia in a Patient with Systemic Lupus Erythematosus

Overview
Journal Rheumatology (Oxford)
Publisher Oxford University Press
Specialty Rheumatology
Date 2012 Apr 20
PMID 22513150
Citations 9
Authors
Francisco J Garcia-Hernandez
Rocio Gonzalez-Leon
Maria J Castillo-Palma
Celia Ocana-Medina
Julio Sanchez-Roman
Affiliations
Soon will be listed here.
Citing Articles

Interleukin 6 exacerbates the progression of warm autoimmune hemolytic anemia by influencing the activity and function of B cells.

Zhao M, Chen L, Yang J, Zhang Z, Wang H, Shao Z Sci Rep. 2023; 13(1):13231.

PMID: 37580421 PMC: 10425344. DOI: 10.1038/s41598-023-40239-w.

Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.

Athanassiou P, Athanassiou L Life (Basel). 2023; 13(7).

PMID: 37511872 PMC: 10381582. DOI: 10.3390/life13071496.

Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidance.

Marinho A, Delgado Alves J, Fortuna J, Faria R, Almeida I, Alves G Front Immunol. 2023; 14:1117699.

PMID: 37138867 PMC: 10150407. DOI: 10.3389/fimmu.2023.1117699.

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review.

Jung J, Kim M, Suh C, Kim H Pediatr Rheumatol Online J. 2018; 16(1):79.

PMID: 30547812 PMC: 6295005. DOI: 10.1186/s12969-018-0296-z.

The Two-Faced Cytokine IL-6 in Host Defense and Diseases.

Narazaki M, Kishimoto T Int J Mol Sci. 2018; 19(11).

PMID: 30423923 PMC: 6274717. DOI: 10.3390/ijms19113528.